Absci Corp (NAS:ABSI)
$ 2.77 -0.21 (-7.05%) Market Cap: 342.27 Mil Enterprise Value: 230.64 Mil PE Ratio: 0 PB Ratio: 1.69 GF Score: 54/100

Absci Corp at Cowen Health Care Conference - Fireside Chat Transcript

Mar 08, 2023 / 05:50PM GMT
Release Date Price: $2.06 (-3.74%)
Steven Mah
TD Cowen - Analyst

Hi. Our next team here in the data-driven antibody discovery space is Absci. It's my pleasure to welcome Sean McClain, Founder and CEO of Absci; Josh Meier, Head of AI; and Greg Schiffman, Chief Financial Officer. (Conference Instructions)

All right. So Sean, maybe you can just give a quick introduction to Absci for those that are unfamiliar with the company.

Sean McClain
Absci Corporation - Founder, CEO & Director

Yeah, absolutely. So Absci is a generative AI drug-creation company that is really going from this paradigm of drug discovery, where you're finding the needle in the haystack to drug creation, where you're actually being able to create the needle. In our case, the biologic, being able to combine biology along with generative AI to actually start designing antibodies with the specifications you want the first go around, being able to hit the location of the target that you want, the affinity, and have all the developability and manufacturability.

And what this is going to start enabling is us to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot